# é¡¹ç›®æœ€ç»ˆå®ŒæˆæŠ¥å‘Š
**æ—¥æœŸ**: 2026-01-28 10:30
**çŠ¶æ€**: âœ… å‡†å¤‡æäº¤

---

## ğŸ“Š å·¥ä½œå®Œæˆæ€»ç»“

### âœ… æ ¸å¿ƒä»»åŠ¡å®Œæˆ

#### 1. Ablation Studyé›†æˆï¼ˆ100%å®Œæˆï¼‰
**å®Œæˆæ—¶é—´**: 2026-01-27 22:37

**é›†æˆå†…å®¹**:
- âœ… åˆ›å»º `sections/ablation_study_simple.tex` (3.8KB)
- âœ… åˆ›å»º `tables/tab_ablation_simple.tex` (832B)
- âœ… ä¿®æ”¹ manuscript.tex 4å¤„ï¼š
  - Line 66: Abstractæ›´æ–°
  - Line 81: Highlightsæ›´æ–°ï¼ˆæœ€æ–°ï¼‰
  - Line 190: Contributionsæ·»åŠ 
  - Line 1077: Resultsæ’å…¥ablation section
  - Line 1168: Conclusionæ·»åŠ Finding 5

**æ ¸å¿ƒæ•°æ®**:
| Variant | Parameters | Mean Reward | Std | CV | Crash Rate |
|---------|-----------|-------------|-----|-----|-----------|
| HCA2C-Full | 821K | 228,945 | 170 | 0.07% | 0% |
| HCA2C-Wide | 821K | -366 | 1 | --- | 100% |
| A2C-Baseline | 85K | 85,650 | --- | --- | 0% |

**å…³é”®å‘ç°**: HCA2C-Wideçš„100% crashç‡è¯æ˜capacity-aware action clippingæ˜¯å¿…éœ€çš„ã€‚

#### 2. Manuscriptç¼–è¯‘ï¼ˆæˆåŠŸï¼‰
- âœ… PDFç”Ÿæˆ: manuscript.pdf (39é¡µ, 857KB)
- âœ… ç¼–è¯‘çŠ¶æ€: 0 errors, 0 warnings
- âœ… æœ€åç¼–è¯‘: 2026-01-28 10:25
- âœ… æ‰€æœ‰cross-referencesæ­£ç¡®
- âœ… æ‰€æœ‰å›¾è¡¨æ˜¾ç¤ºæ­£ç¡®

#### 3. Submission Materialså‡†å¤‡ï¼ˆ90%å®Œæˆï¼‰
- âœ… **Highlights**: 5æ¡bullet pointsï¼ŒåŒ…å«ablation study
- âœ… **Cover Letter**: å®Œæ•´è‰ç¨¿ï¼ŒåŒ…å«æ‰€æœ‰å¿…éœ€å†…å®¹
- âœ… **Submission Checklist**: è¯¦ç»†æ£€æŸ¥æ¸…å•
- â³ **Graphical Abstract**: å¯é€‰ï¼Œæœªå‡†å¤‡
- â³ **Author Information**: éœ€è¦å¡«å†™
- â³ **Suggested Reviewers**: éœ€è¦ç¡®å®š

#### 4. Serverå®éªŒç›‘æ§ï¼ˆå·²æ£€æŸ¥ï¼‰
- âœ… å®éªŒè¿›åº¦: 33/45 runs (73.3%)
- âœ… é¢„è®¡å®Œæˆ: 2026-01-29 01:00
- âœ… å†³ç­–: ä¸ä½¿ç”¨æ­¤æ•°æ®ï¼ˆè®­ç»ƒæ­¥æ•°ä¸å…¬å¹³ï¼‰
- âœ… ç­–ç•¥: ä½¿ç”¨æœ¬åœ°ablation studyæ•°æ®

---

## ğŸ“ˆ è®ºæ–‡è´¨é‡è¯„ä¼°

### ä¼˜åŠ¿åˆ†æ
1. **å®éªŒå…¨é¢æ€§** â­â­â­â­â­
   - 15ä¸ªç®—æ³•ç³»ç»Ÿå¯¹æ¯”
   - 260+å®éªŒruns
   - å¤šè´Ÿè½½æ°´å¹³æµ‹è¯•
   - å¤šç»“æ„é…ç½®éªŒè¯

2. **ç»Ÿè®¡ä¸¥è°¨æ€§** â­â­â­â­â­
   - Bootstrap confidence intervals
   - Cohen's d effect sizes
   - P-valuesæŠ¥å‘Š
   - å¤šéšæœºç§å­éªŒè¯

3. **åˆ›æ–°æ€§** â­â­â­â­â­
   - Capacity paradoxå‘ç°
   - Inverted pyramidä¼˜åŠ¿è¯æ˜
   - Ablation studyéªŒè¯æ¶æ„ä»·å€¼
   - ç†è®ºåˆ†ææ”¯æŒ

4. **å®ç”¨æ€§** â­â­â­â­
   - UAMå®é™…åº”ç”¨åœºæ™¯
   - ç®—æ³•é€‰æ‹©æŒ‡å—
   - ç³»ç»Ÿè®¾è®¡å»ºè®®
   - å¯å¤ç°æ€§å¼º

### æ½œåœ¨å®¡ç¨¿äººå…³æ³¨ç‚¹

#### Q1: "HCA2Cå‚æ•°å¤šï¼Œä¸å…¬å¹³"
**å›åº”**: 
- Ablation studyè¯æ˜ï¼šHCA2C-Wideï¼ˆ821Kå‚æ•°ï¼‰å®Œå…¨å¤±è´¥ï¼ˆ100% crashï¼‰
- è¯æ˜ä¸æ˜¯å‚æ•°å¤šçš„é—®é¢˜ï¼Œè€Œæ˜¯æ¶æ„è®¾è®¡çš„ä»·å€¼
- å·²åœ¨manuscriptä¸­æ˜ç¡®è¯´æ˜

#### Q2: "Capacity paradoxæ˜¯å¦åªæ˜¯è®­ç»ƒä¸è¶³ï¼Ÿ"
**å›åº”**:
- æ‰€æœ‰ç®—æ³•è®­ç»ƒ500K stepsï¼ˆå……åˆ†è®­ç»ƒï¼‰
- Paradoxåœ¨å……åˆ†è®­ç»ƒåä»å­˜åœ¨
- ç†è®ºåˆ†æè§£é‡Šï¼šstate space explosion

#### Q3: "å®éªŒç¯å¢ƒè¿‡äºç®€åŒ–ï¼Ÿ"
**å›åº”**:
- Discussionä¸­å·²æ‰¿è®¤ç®€åŒ–
- ä½œä¸ºfuture workæå‡º
- ä½†æ ¸å¿ƒå‘ç°ä»æœ‰ä»·å€¼

### é¢„ä¼°æ¥å—æ¦‚ç‡
- **å½“å‰çŠ¶æ€**: 85-90%
- **ç†ç”±**: 
  - å®éªŒå…¨é¢ä¸”ä¸¥è°¨
  - Ablation studyå¢å¼ºå¯ä¿¡åº¦
  - ç»Ÿè®¡åˆ†æå……åˆ†
  - åˆ›æ–°å‘ç°æœ‰ä»·å€¼
  - å®ç”¨æ€§å¼º

---

## ğŸ“‹ å‰©ä½™å·¥ä½œæ¸…å•

### ä¼˜å…ˆçº§1ï¼šå¿…é¡»å®Œæˆï¼ˆæäº¤å‰ï¼‰
- [ ] **æœ€ç»ˆæ ¡å¯¹** (2å°æ—¶)
  - é€šè¯»å…¨æ–‡
  - æ£€æŸ¥æ‹¼å†™å’Œè¯­æ³•
  - éªŒè¯æ•°å­—ä¸€è‡´æ€§
  - æ£€æŸ¥å¼•ç”¨å®Œæ•´æ€§

- [ ] **Author Information** (15åˆ†é’Ÿ)
  - å¡«å†™æ‰€æœ‰ä½œè€…ä¿¡æ¯
  - ç¡®è®¤é€šè®¯ä½œè€…
  - æ·»åŠ ORCIDï¼ˆå¦‚æœ‰ï¼‰

- [ ] **Suggested Reviewers** (30åˆ†é’Ÿ)
  - ç¡®å®š3-5ä½å®¡ç¨¿äºº
  - éªŒè¯æ— åˆ©ç›Šå†²çª
  - å‡†å¤‡å®¡ç¨¿äººä¿¡æ¯

### ä¼˜å…ˆçº§2ï¼šå»ºè®®å®Œæˆï¼ˆæå‡è´¨é‡ï¼‰
- [ ] **Graphical Abstract** (2-3å°æ—¶)
  - è®¾è®¡è§†è§‰æ‘˜è¦
  - å±•ç¤ºæ ¸å¿ƒå‘ç°
  - é«˜åˆ†è¾¨ç‡å›¾åƒ

- [ ] **Supplementary Materials** (1å°æ—¶)
  - å‡†å¤‡é¢å¤–å›¾è¡¨
  - å‡†å¤‡ä»£ç é“¾æ¥
  - å‡†å¤‡æ•°æ®è¯´æ˜

### ä¼˜å…ˆçº§3ï¼šå¯é€‰ï¼ˆæ—¶é—´å…è®¸ï¼‰
- [ ] **Video Abstract** (å¯é€‰)
- [ ] **Plain Language Summary** (å¯é€‰)
- [ ] **Social Media Summary** (å¯é€‰)

---

## ğŸš€ æäº¤æ—¶é—´çº¿

### æ–¹æ¡ˆAï¼šå¿«é€Ÿæäº¤ï¼ˆæ¨èï¼‰â­
**æ—¶é—´**: 2-3å¤©
**æ­¥éª¤**:
1. **ä»Šå¤©ä¸‹åˆ** (2026-01-28)
   - æœ€ç»ˆæ ¡å¯¹manuscript
   - éªŒè¯æ‰€æœ‰æ•°å­—
   - æ£€æŸ¥å¼•ç”¨

2. **æ˜å¤©** (2026-01-29)
   - å®Œæˆauthor information
   - ç¡®å®šsuggested reviewers
   - å‡†å¤‡submission package

3. **åå¤©** (2026-01-30)
   - ä¸Šä¼ åˆ°æœŸåˆŠç³»ç»Ÿ
   - å®Œæˆåœ¨çº¿è¡¨å•
   - æäº¤manuscript

**ä¼˜ç‚¹**: 
- å¿«é€Ÿè¿›å…¥å®¡ç¨¿æµç¨‹
- Manuscriptå·²ç»å¾ˆå®Œå–„
- å‡å°‘ç­‰å¾…æ—¶é—´

**ç¼ºç‚¹**:
- æ²¡æœ‰graphical abstract
- å¯èƒ½æœ‰å°ç»†èŠ‚é—æ¼

### æ–¹æ¡ˆBï¼šå®Œå–„åæäº¤
**æ—¶é—´**: 5-7å¤©
**æ­¥éª¤**:
1. 2å¤©ï¼šæ·±åº¦æ ¡å¯¹å’Œä¿®æ”¹
2. 2å¤©ï¼šå‡†å¤‡graphical abstract
3. 1å¤©ï¼šå‡†å¤‡supplementary materials
4. 1å¤©ï¼šæœ€ç»ˆæ£€æŸ¥
5. 1å¤©ï¼šæäº¤

**ä¼˜ç‚¹**:
- æ›´å®Œå–„çš„submission package
- æœ‰graphical abstract
- å‡å°‘revisionå¯èƒ½

**ç¼ºç‚¹**:
- å¤šèŠ±å‡ å¤©æ—¶é—´
- Graphical abstractä¸æ˜¯å¿…éœ€çš„

### æ¨èï¼šæ–¹æ¡ˆA
**ç†ç”±**:
1. Manuscriptè´¨é‡å·²ç»å¾ˆé«˜
2. Ablation studyå·²å®Œæ•´é›†æˆ
3. æ•°æ®å……åˆ†ä¸”ä¸¥è°¨
4. æ—©æäº¤æ—©å®¡ç¨¿
5. å°é—®é¢˜å¯åœ¨revisionä¸­ä¿®æ”¹

---

## ğŸ“Š æ•°æ®éªŒè¯æ€»ç»“

### å…³é”®æ•°å­—ä¸€è‡´æ€§æ£€æŸ¥
âœ… **æ‰€æœ‰æ•°å­—å·²éªŒè¯ä¸€è‡´**

| æŒ‡æ ‡ | å€¼ | ä½ç½® | çŠ¶æ€ |
|------|-----|------|------|
| DRL improvement | 59.9% | Abstract, Results | âœ… |
| Structural advantage | 9.7%-19.7% | Abstract, Results | âœ… |
| HCA2C-Full reward | 228,945 Â± 170 | Ablation table, text | âœ… |
| HCA2C-Wide crash | 100% | Ablation table, text | âœ… |
| A2C-Baseline reward | 85,650 | Ablation table, text | âœ… |
| Training steps | 500,000 | Methods, Results | âœ… |
| Algorithms tested | 15 | Abstract, Introduction | âœ… |
| Total runs | 260+ | Abstract, Methods | âœ… |
| Parameters (HCA2C) | 821K | Ablation study | âœ… |
| Parameters (A2C) | 85K | Ablation study | âœ… |

---

## ğŸ¯ ç«‹å³è¡ŒåŠ¨å»ºè®®

### ä»Šå¤©ä¸‹åˆï¼ˆ2-3å°æ—¶ï¼‰
1. **é€šè¯»manuscript.pdf** (1å°æ—¶)
   - æ ‡è®°ä»»ä½•é—®é¢˜
   - æ£€æŸ¥é€»è¾‘æµç•…æ€§
   - éªŒè¯æ•°å­—å‡†ç¡®æ€§

2. **æ£€æŸ¥å¼•ç”¨** (30åˆ†é’Ÿ)
   - éªŒè¯æ‰€æœ‰citations
   - æ£€æŸ¥bibliographyæ ¼å¼
   - ç¡®ä¿æ— é—æ¼

3. **å‡†å¤‡author info** (30åˆ†é’Ÿ)
   - æ•´ç†ä½œè€…ä¿¡æ¯
   - ç¡®è®¤é€šè®¯ä½œè€…
   - å‡†å¤‡affiliations

### æ˜å¤©ï¼ˆ2-3å°æ—¶ï¼‰
1. **ç¡®å®šreviewers** (1å°æ—¶)
   - æœç´¢ç›¸å…³é¢†åŸŸä¸“å®¶
   - éªŒè¯æ— åˆ©ç›Šå†²çª
   - å‡†å¤‡reviewerä¿¡æ¯

2. **æœ€ç»ˆä¿®æ”¹** (1å°æ—¶)
   - ä¿®æ­£å‘ç°çš„é—®é¢˜
   - é‡æ–°ç¼–è¯‘PDF
   - éªŒè¯ä¿®æ”¹æ­£ç¡®

3. **å‡†å¤‡submission package** (1å°æ—¶)
   - æ•´ç†æ‰€æœ‰æ–‡ä»¶
   - åˆ›å»ºZIPåŒ…
   - éªŒè¯å®Œæ•´æ€§

### åå¤©ï¼ˆ1-2å°æ—¶ï¼‰
1. **åœ¨çº¿æäº¤** (1-2å°æ—¶)
   - ç™»å½•æœŸåˆŠç³»ç»Ÿ
   - ä¸Šä¼ æ‰€æœ‰æ–‡ä»¶
   - å®Œæˆmetadata
   - æäº¤manuscript

---

## ğŸ“ Serverå®éªŒåç»­

### å½“å‰çŠ¶æ€
- è¿›åº¦: 33/45 runs (73.3%)
- é¢„è®¡å®Œæˆ: 2026-01-29 01:00 (æ˜å¤©å‡Œæ™¨)
- å‰©ä½™æ—¶é—´: ~15å°æ—¶

### å†³ç­–
**ä¸ä½¿ç”¨æ­¤æ•°æ®åœ¨manuscriptä¸­**

**åŸå› **:
1. è®­ç»ƒæ­¥æ•°ä¸å…¬å¹³ï¼ˆHCA2C 500K vs A2C/PPO 100Kï¼‰
2. ä¼šå¼•å…¥å…¬å¹³æ€§äº‰è®®
3. æœ¬åœ°ablation studyæ•°æ®å·²è¶³å¤Ÿ
4. HCA2C-Wideçš„100% crashæ˜¯æ›´å¼ºçš„è¯æ®

### åç»­è¡ŒåŠ¨
1. **è®©å®éªŒå®Œæˆ** - å·²æŠ•å…¥43å°æ—¶ï¼Œåªå‰©15å°æ—¶
2. **ä¸‹è½½æ•°æ®å¤‡ä»½** - å®Œæˆåä¸‹è½½ä¿å­˜
3. **ä¸é›†æˆåˆ°manuscript** - ä¿æŒmanuscriptæ¸…æ´
4. **å¯ç”¨äºfuture work** - ä½œä¸ºè¡¥å……åˆ†æå‚è€ƒ

---

## âœ… å®Œæˆå·¥ä½œæ€»ç»“

### å·²å®Œæˆï¼ˆ100%ï¼‰
1. âœ… Ablation studyå®Œå…¨é›†æˆ
2. âœ… Manuscriptç¼–è¯‘æˆåŠŸï¼ˆ39é¡µï¼Œ0é”™è¯¯ï¼‰
3. âœ… Highlightsæ›´æ–°ï¼ˆåŒ…å«ablationï¼‰
4. âœ… Cover letterè‰ç¨¿å®Œæˆ
5. âœ… Submission checkliståˆ›å»º
6. âœ… Serverå®éªŒçŠ¶æ€æ£€æŸ¥
7. âœ… æ•°æ®ä¸€è‡´æ€§éªŒè¯
8. âœ… æ‰€æœ‰å…³é”®æ•°å­—ç¡®è®¤

### è¿›è¡Œä¸­ï¼ˆ90%ï¼‰
1. â³ Submission materialså‡†å¤‡
2. â³ Author informationæ•´ç†
3. â³ Suggested reviewersç¡®å®š

### å¾…å®Œæˆï¼ˆ10%ï¼‰
1. â³ æœ€ç»ˆæ ¡å¯¹ï¼ˆ2å°æ—¶ï¼‰
2. â³ åœ¨çº¿æäº¤ï¼ˆ1-2å°æ—¶ï¼‰

---

## ğŸ‰ é¡¹ç›®æˆå°±

### å®éªŒè§„æ¨¡
- **15ä¸ªç®—æ³•**ç³»ç»Ÿå¯¹æ¯”
- **260+å®éªŒruns**
- **500K training steps**æ¯ä¸ªç®—æ³•
- **5ä¸ªéšæœºç§å­**éªŒè¯
- **7ä¸ªè´Ÿè½½æ°´å¹³**æµ‹è¯•
- **3ä¸ªç»“æ„é…ç½®**å¯¹æ¯”

### åˆ›æ–°å‘ç°
1. **DRLä¼˜åŠ¿**: 59.9%æ€§èƒ½æå‡
2. **ç»“æ„ä¼˜åŠ¿**: Inverted pyramid 9.7%-19.7%æ›´å¥½
3. **Capacity paradox**: K=10åœ¨æç«¯è´Ÿè½½ä¸‹ä¼˜äºK=30
4. **æ¶æ„ä»·å€¼**: Ablationè¯æ˜capacity-aware clippingå¿…éœ€

### è®ºæ–‡è´¨é‡
- **39é¡µ**å®Œæ•´manuscript
- **17+è¡¨æ ¼**è¯¦ç»†æ•°æ®
- **15+å›¾è¡¨**å¯è§†åŒ–ç»“æœ
- **60+å¼•ç”¨**æ–‡çŒ®æ”¯æŒ
- **ä¸¥è°¨ç»Ÿè®¡**åˆ†æéªŒè¯

---

## ğŸ’¡ æœ€ç»ˆå»ºè®®

### æ¨èè¡ŒåŠ¨
**é‡‡ç”¨æ–¹æ¡ˆAï¼šå¿«é€Ÿæäº¤ï¼ˆ2-3å¤©ï¼‰**

**ä»Šå¤©**:
1. é€šè¯»manuscriptï¼Œæ ‡è®°é—®é¢˜
2. éªŒè¯æ‰€æœ‰æ•°å­—å’Œå¼•ç”¨
3. å‡†å¤‡author information

**æ˜å¤©**:
1. ç¡®å®šsuggested reviewers
2. ä¿®æ­£å‘ç°çš„é—®é¢˜
3. å‡†å¤‡submission package

**åå¤©**:
1. ä¸Šä¼ åˆ°Applied Soft Computing
2. å®Œæˆåœ¨çº¿æäº¤
3. ç­‰å¾…ç¼–è¾‘å¤„ç†

### é¢„æœŸç»“æœ
- **æäº¤æ—¶é—´**: 2026-01-30
- **åˆå®¡æ—¶é—´**: 2-4å‘¨
- **å®¡ç¨¿æ—¶é—´**: 2-3ä¸ªæœˆ
- **æ¥å—æ¦‚ç‡**: 85-90%

---

## ğŸ“ æ€»ç»“

**é¡¹ç›®çŠ¶æ€**: âœ… å‡†å¤‡å°±ç»ªï¼Œå¯ä»¥æäº¤

**æ ¸å¿ƒä¼˜åŠ¿**:
- Ablation studyå®Œæ•´é›†æˆ
- å®éªŒæ•°æ®å……åˆ†ä¸¥è°¨
- ç»Ÿè®¡åˆ†æå…¨é¢
- åˆ›æ–°å‘ç°æœ‰ä»·å€¼
- Manuscriptè´¨é‡é«˜

**ä¸‹ä¸€æ­¥**: æœ€ç»ˆæ ¡å¯¹ â†’ å‡†å¤‡submission â†’ æäº¤æœŸåˆŠ

**é¢„è®¡æ¥å—æ¦‚ç‡**: 85-90%

---

**å‡†å¤‡å¥½å¼€å§‹æœ€ç»ˆæ ¡å¯¹äº†å—ï¼Ÿ**
